Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Previously the hospital offered the clinic to those born on or after January 1, 2024, without a primary care practitioner.

As of this month, about 37 percent of adults 18 and older had received a seasonal flu shot, while 19 percent had received ...

RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...

Coronavirus cases have been flat locally, likely due to the outsized surge that occurred this past summer, but the flu ...

Experts say the RSV vaccines were rigorously tested and the benefits of the shot outweigh the risks for many of the oldest ...

Winter and family holiday gatherings often bring a surge in a wide variety of respiratory issues. Here's what to watch for.

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

The NHS says the RSV vaccine is recommended from 28 weeks of pregnancy, to protect the baby for the first few months after ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

FluMist, a self-administered flu vaccine, is approved for ages 2-49, but will be available in the 2025-2026 season. RSV vaccination is vital for older adults, with new guidelines for those aged 60-74, ...